Edison Investment Research is terminating coverage on Avalo Therapeutics (AVTX), Open Orphan (ORPH), and Aditxt (ADTX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.